Background: Although European Borrelia burgdorferi sensu lato isolates have been divided into five genospecies, specific tools for the serotype characterization of only three genospecies are available. Monoclonals antibodies (mAbs) H3TS, D6 and I17.3 identify B. burgdorferi sensu stricto (ss.), B. garinii and B. afzelii respectively, but no mAbs are available to identify B. valaisiana. In the same way, specific primers exist to amplify the OspA gene of B. burgdorferi ss., B. garinii and B. afzelii. The aim of the study was to develop species-specific mAb and PCR primers for the phenotypic and genetic identification of B. valaisiana.
Background
Lyme borreliosis (LB) caused by a spirochetal species Borrelia burgdorferi sensu lato (sl.) is a multisystemic illness distributed worldwide [1] . In North America and Eurasia, LB is the most common tick-borne disease [2] . On the basis of protein profiles, DNA-DNA relatedness and rRNA gene restriction pattern, B. burgdorferi sl. strains have been previously divided into three species: B. burgdorferi sensu stricto (ss.), B. garinii and B. afzelii [3, 4] . B. burgdorferi ss. was found in ticks and patients infected in Europe as well as in North America, whereas B. garinii and B. afzelii were only found in ticks and patients infected in Eurasia [4, 5] .
B. andersonii and B. bissettii were described in North America [6, 7] , while B. japonica has been defined in Japan [8] and B. lusitaniae in Portugal [9] .
First isolated in Valais-CH, from an I. ricinus tick, VS116 was characterized as B. valaisiana novel species [10] . As other species, it appeared that its geographical distribution was not uniform. In Switzerland, Scandinavia and the Netherlands, B. valaisiana was less frequently isolated than B. garinii and B. afzelii. In Ireland however, B. valaisiana was described as the most prevalent genospecies [11] . More recently, B. valaisiana has been isolated in Japan and East Asia from I. nipponensis, I. columnae and I. granulatus [12, 13] .
An association between clinical outcome and infection by strains of different genospecies has been suggested and suspicion of a pathogenic potential of B. valaisiana in humans was described [14, 15] . Therefore, genospecies classification may increase the sensitivity of serologic and genetic analysis by appropriate choice of target antigens. Electrophoretic mobility of the major proteins allows us to distinguish most Borrelia genospecies, but monoclonal antibodies (mAb) are used to formally identify species on immunoblots. Up to now, only B. burgdorferi ss., B. garinii and B. afzelii among European isolates could be characterized by mAbs, H3TS was directed against OspA of B burgdorferi ss., D6 directed against a 12 kDa protein of B. garinii and I17.3 reacted with OspB of B. afzelii [16] ; specific primers GI, GII and GIII were directed against ospA gene of Borrelia burgdorferi ss, B. garinii and B. afzelii, respectively [17] . In this study, the major outer surface protein OspA of the reference strain VS116 was selected as antigen for mAbs production, because of its particular protein profile in SDS-page and its potential discriminative utility. In the same way, we have designed primers specific to ospA gene of B. valaisiana. We described a mAb and primers specific to the major group of European B. valaisiana.
Methods

Bacterial strains
The Borrelia burgdorferi sl. strains used in this study are listed in Table 1 [see Additional file 1].
All Borrelia isolates were grown in MKP medium [30] at 33°C. Extraction of DNA was performed as described previously [16] . B. burgdorferi sl. isolates were all characterized by RFLP of amplicons digested by Mse I (Boehringer, Mannheim, Germany) and Dra I (Life technology, CH) as described by Postic [18] . All the Borrelia isolates were submitted to reactivity of mAb H3TS, I 17.3, D6 and A116k [16] B. turicatae, B. parkeri, B. coriaceae, B. anserina were kindly provided by T. Schwan (Rocky Mount. Lab, Hamilton, MT, USA). Other bacteria isolates listed on Table 1 were cultured and characterized by usual laboratory techniques in our department of bacteriology.
ELISA for screening of hybridoma supernatants
Low-passages, whole-cell of VS215 isolate of B. burgdorferi ss., VS102 of B. garinii, VS461 of B. afzelii and VS116 of B. valaisiana were harvested in the log-phase growth, centrifuged and the resulting cell pellet was rinsed twice with PBS (Phosphate-Buffered Saline, pH 7.2, 0.1 M) with MgCl 2 5 mM. The cells were suspended in distilled water. Concentrations were equally adjusted to 10 µg/ml and the four antigens were heated 5 min with 5% SDS at 37°C then 15 min at 95°C. The microwells of the ELISA plates were coated with the four strains in Na 2 CO 3 , 0.1 M, pH 9.6 at 4°C overnight. The wells were washed four times in PBS-T (PBS with 0.01% Tween) and blocked for 1 hour with BSA 1% in PBS and again washed four times. Supernatants of hybridomas were diluted 1/3 in PBS-T. Plates were incubated at 37°C for 1 hour and then washed four times with PBS-T. The conjugate (goat anti-mouse polyvalent conjugated to alkaline phosphatase (Sigma)) diluted 1/1000 in PBS-T was added and incubated at 37°C for 2 hours. After four washing steps, substrate (para-Nitrophenylphosphate, Virion, Rüschlikon, Switzerland) was added and plate incubated at room temperature for 15 min. ODs were read by a microplate reader at 405 nm (with reference OD at 620 nm). 
Development of B.valaisiana specific monoclonal antibodies
The strain VS116 was used to produce mAbs specific to B. valaisiana. 200 µg of proteins were separated on a 12% Sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Gel was cut into three parts. Both external parts were stained with Coomassie blue and used as references to cut the OspA band from the medium part of the gel. The OspA portion was thereafter used for immunization and the rest of the gel stained to confirm the extraction of the selected protein.
The immunization kit of ISL (Readysysteme, Zursach, AG-CH) was used. An estimated fraction of 20 µg proteins of a 12% gel containing the OspA band was incubated 48 h with monolayer of support cells provided with the kit. One mouse was sacrificed to extract splenocytes. The splenocytes were incubated four days in immunization medium with 20 µg of fresh antigen and pre-primed support cells.
Immunogen splenocyte suspension was then prepared and mixed with myeloma cells provided with the kit (ratio 1:10 with the splenocytes). The cells were fused with polyethylen glycol in HAT (Hypoxanthine, Aminopterin, Thymidine) medium and the resultant hybridomas were seeded into multi-well plates.
Four days later, supernatants were screened for antibody production by ELISA as described above and specificity of positive supernatants was then confirmed by using an immunoblot assay with VS215 (B. burgdorferi ss.), VS102 (B. garinii), VS 461 (B. afzelii) and VS116 (B. valaisiana) as antigens [15] . The hybridomas which produced specific mAbs reactive to B. valaisiana were cloned by the limiting dilution technique.
Subtyping of mAbs was performed by immunoblot with peroxidase-conjugated rabbit antibodies specific for different isotypes of mouse immunoglobulins (Pierce, Rockford IL, USA)
PCR assay
Based on the comparison of ospA sequences, the following oligonucleotide primers specific to B. valaisiana were used in this study : Bval 1F 5'-TGCTGAAAATGCTACAAAAG-CAGT-3' (forward primer) and Bval 1R 5'-CAA-GACAAAACTTGTATTTACAAAAC-3' (reverse primer [32] .
The nucleotide sequence of ospA gene from strain NE231 was determined by the dideoxy chain termination technique with the "Prism ready reaction dye deoxy-terminator cycle sequencing" kit (Applied Biosystem). The ospA sequence of NE231 has been entered in the EMBL/Genbank databases with accession number AJ249467.
Results and Discussion
The characterization of B. valaisiana was usually proceeded by rRNA gene restriction pattern after digestion by EcoRI and HindIII which contain three and four DNA fragments respectively [10] , by RFLP of amplicons resulting from intergenic spacer of 23S-5S rRNA which contains four DNA fragments [18] or by hybridization on amplicons of 16s RNA gene [14] . Species specific primers designed on 16s RNA were described including Borrelia burgdorferi ss, B. garinii, B. afzelii and B. valaisiana [19] . The primers we designed in the OspA gene, as well as the monoclonal antibody evaluated here allowed us to specifically identified the major European group of B. valaisiana, as previously described as group I [20] .
Phenotypic [16, 21, 22] The detection threshold of this PCR assay was determined by performing amplification reactions on a controlled number of cells. A stock sample of B. valaisiana strain VS116 was serially diluted in phosphate saline buffer. The number of Borrelia cells (± 2.0 × 10 7 cells/ml) in the stock sample was determined by dark-field microscopy, and aliquots of the dilution were tested for amplification using these primers. It was found that a template DNA input corresponding to about 5 spirochetes was sufficient to detect the expected amplified fragment (data not shown). No signal was observed when template DNA was omitted from the amplification reaction.
The specificity of the PCR assay was evaluated on the 90 B. burgdorferi sensu lato strains and 14 unrelated bacterial species (Table 1 [see Additional file 1] and Table 1 ), previously tested by using A116k mAb. Three B. garinii (SO1, BITS, and VS711) and one B. lusitaniae (BR41) strains were positive. The specificity was therefore 97 %. None of the 14 unrelated bacteria showed an amplified product with these primers. Twenty-one out of the 24 B. valaisiana strains had an amplified product at the expected size (Table 1 [see Additional file 1] ). The strains NE231, M7 and M53 were not amplified with these primers.
Comparison and alignment of the NE231 OspA deduced amino acid sequence with those of 28 B. burgdorferi sensu lato strains was performed. Based on this comparison, the 6 analysed B. valaisiana strains (UK, AR-2, VS116, M53, M7 and NE231) confirmed the existence of 2 subgroups (Figure 2 ). The subgroup I consists of three B. valaisiana isolates (UK, AR-2 and VS116). The amino acid sequences of OspA from these isolates were 98.9 % to 99.6 % homologous (Table 3 [see Additional file 2] ). Subgroup II contains three B. valaisiana isolates (M53, M7 and NE231). OspA sequences of M7 and M53 were identical. These two sequences had a homology of 98.5 % (4 amino acid substitutions) with the OspA sequence of strain NE231. The average identity of the deduced amino acid sequences of the OspA proteins between subgroup I and II was about 69.9 %, and between B. valaisiana and representative isolates from other B. burgdorferi sensu lato species varied from 62.1 % to 75 %. These data were concordant with the two subgroups described by Wang [20] , whose results were based on the OspA protein sequence of eight B. valaisiana isolates (subgroup I: VS116, M19, M49, M52, AR-2 and UK-c16; subgroup II: M7 and M53). In addition, a similar divergence has already been suggested Dendrogram of B. burgdorferi sensu lato isolates (n = 30). The B. valaisiana isolates clustered into 3 separated branches confirming the results previously published by Wang [20] and Masuzawa [12] . 
B. valaisiana subgroup III
by Masuzawa [12] . His hypothesis was based on molecular masses of the OspA and on sequences of the ospA gene of Asian strain Am501 compared to that of the reference strain VS116. However, a BLAST alignment of the Am501 OspA deduced amino acid sequence with that of M53 OspA revealed only 68% identities (data not shown). Taken together, these results could mean that some Asian B. valaisiana belong to a third group (Figure 2) , distinct of group I (VS116) and group II (M53).
The heterogeneity of B. valaisiana species has been previously evidenced by several authors and on diverse targets such as rrf-rrl spacer, rrs, fla and OspC genes but was not revealed by using standard genotyping methods such as ribotyping [10] , RAPD [24] and RFLP [25] . The heterogeneity of the ospA gene sequences was previously reported within the B. garinii species [17, 23, 25] . Our data, as well as those from previous publications [12, 20] indicated that such major ospA gene differences also occur within another Borrelia genospecies. The ospA gene encodes an outer membrane lipoprotein that is differentially expressed by B. burgdorferi sensu lato in ticks and in mammals [26] . Although the role of the OspA protein is not fully understood, OspA may be important in the bacterium-host interaction. Studies have indicated that OspA protein possesses B-cell mitogenic and cytokine-stimulatory properties [27, 28] . It seems also that OspA may play a role in the adherence of B. burgdorferi sensu lato to different eucaryotic cells [29] . Taking into account all these features, the heterogeneity observed within the OspA protein sequences could be a key factor in tissue specificity or in the infection of specific hosts.
Conclusion
The existence of two subgroups among European B. valaisiana species was confirmed, as well as the existence of a third group of B. valaisiana in Asia, as it has already been described. The heterogeneity was first observed on protein profile as the OspA band of NE231, M7, M53 and Frank presented a molecular weight lower than the reference strain VS116 [22] . In addition, Wang [20] described the presence of two subgroups based on the OspA protein sequence of eight strains. One monoclonal antibody and PCR primers presented in this study are therefore useful serologic and genetic tools to classify strains of B. valaisiana group I. The lack of reactivity of strain Frank with monoclonal antibody A116k was not concordant with the result of the PCR-amplification of ospA gene. Therefore, further analyses have to be done. The sequence analysis of the complete OspA gene should explain this contradiction. 
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